RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 88 filers reported holding RHYTHM PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $930,000 | +11.1% | 33,945 | +9.1% | 0.00% | 0.0% |
| Q4 2018 | $837,000 | -48.3% | 31,125 | -44.0% | 0.00% | 0.0% |
| Q3 2018 | $1,620,000 | +153.9% | 55,532 | +172.1% | 0.00% | 0.0% |
| Q2 2018 | $638,000 | +114.8% | 20,406 | +36.8% | 0.00% | – |
| Q1 2018 | $297,000 | -29.5% | 14,915 | +2.9% | 0.00% | -100.0% |
| Q4 2017 | $421,000 | – | 14,488 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 909,258 | $10,475,000 | 3.58% |
| NEA Management Company, LLC | 4,912,306 | $56,590,000 | 1.64% |
| RA Capital Management | 4,871,067 | $56,115,000 | 1.22% |
| Pinz Capital Management, LP | 148,475 | $1,710,000 | 1.07% |
| Samsara BioCapital, LLC | 345,293 | $3,978,000 | 1.00% |
| Bell & Brown Wealth Advisors, LLC | 117,400 | $1,352,000 | 0.61% |
| Rock Springs Capital Management LP | 1,237,026 | $14,251,000 | 0.36% |
| ACT CAPITAL MANAGEMENT, LLC | 27,500 | $317,000 | 0.34% |
| Endurant Capital Management LP | 105,792 | $1,219,000 | 0.32% |
| Baker Brothers Advisors | 4,125,062 | $47,521,000 | 0.27% |